FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3142912206> ?p ?o ?g. }

• W3142912206 endingPage "268" @default.
• W3142912206 startingPage "263" @default.
• W3142912206 abstract "OBJECTIVE To evaluate the predictive performance of the individualized drug delivery decision-making system including Smart Dose, PharmVan and JPKD on predicting the Vancomycin plasma concentration and to analyze the related factors affecting the predictive performance. METHODS The clinical data of patients who were treated with Vancomycin and received therapeutic drug monitoring (TDM) admitted to the First Affiliated Hospital of Wenzhou Medical University from January 2018 to July 2020 were retrospectively collected. Smart Dose and PharmVan were used to predict the plasma concentration of Vancomycin of the initial regimen. Smart Dose, PharmVan and JPKD were used to predict the plasma concentration of Vancomycin of the adjustment regimen for patients whose initial steady-state trough concentration were not qualified. The relative predictive error (PE) between the measured plasma concentration and predicted plasma concentration was calculated and box plotted. Mann-Whitney U test was used to evaluate the difference of the absolute value of PE (APE) predicted by each software for Vancomycin plasma concentration. The TDM results were divided into accurate prediction group (APE < 30%) and the inaccurate prediction group (APE ≥ 30%) according to the APE value. Patients and disease characteristics including gender, age, body weight complication, Vancomycin medication and TDM results were collected from electronic medical records. Univariate analysis and multivariate Logistic regression analysis were used to screen the related factors that influence the predictive performance of Smart Dose, PharmVan and JPKD; and receiver operating characteristic curve (ROC curve) was drawn to evaluate its predictive value. RESULTS A total of 185 patients were enrolled, and 258 plasma concentration of Vancomycin were collected, including 185 concentrations of initial regimen and 73 concentration of adjustment regimen. There was no significant difference in the APE of the initial regimen of plasma concentration between Smart Dose and PharmVan. No significant difference in the APE of the adjustment regimen of plasma concentration was found among Smart Dose, PharmVan and JPKD. The accuracy of Smart Dose in predicting the plasma concentration of the adjustment regimen was better than that of the initial regimen [22.94% (10.50%, 36.24%) vs. 29.33% (13.07%, 47.99%), P < 0.05]. The univariate analysis of factors affecting the performance of Smart Dose in predicting the concentration of initial regimen showed that the proportion of patients with hypertension in the accurate prediction group was significantly higher than that in the inaccurate prediction group [43.3% (42/97) vs. 27.3% (24/88), P < 0.05]. The univariate analysis of factors affecting the performance of Smart Dose in predicting the concentration of adjustment regimen showed that the proportion of patients with valvular heart disease in the accurate prediction group was significantly lower than that in the inaccurate prediction group [23.4% (11/47) vs. 46.2% (12/26), P < 0.05]. The univariate analysis of factors affecting the performance of JPKD in predicting the concentration of adjustment regimen showed that the body weight of patients in the accurate prediction group was significantly higher than that in the inaccurate prediction group (kg: 62.8±14.9 vs. 54.8±12.8, P < 0.05). Multivariate Logistic regression analysis indicated that hypertension was a beneficial factor for Smart Dose to predict the initial plasma concentration of Vancomycin [odds ratio (OR) = 0.526, 95% confidence interval (95%CI) was 0.281-0.983, P = 0.044], and low body weight was an independent risk factor for the inaccurate prediction of JPKD for adjustment regimen (OR = 1.042, 95%CI was1.001-1.085, P = 0.043). ROC curve analysis indicated that the area underROC curve (AUC) of the body weight for evaluating the accuracy of JPKD in predicting Vancomycin plasma concentration was 0.663, and 95%CI was 0.529-0.796 (P = 0.023). When the body weight was less than 55.95 kg, the risk of inaccurate prediction of JPKD in predicting Vancomycin plasma concentration was increased, and the predictive sensitivityand specificity were 75% and 60% respectively. CONCLUSIONS There is no significant difference in the predictive performance of Smart Dose, PharmVan or JPKD on Vancomycin plasma concentration. Smart Dose had a better predictive performance for the Vancomycin plasma concentration of adjustment regimen than initial regimen. Smart Dose had a better predictive performance when the patient was concomitant with hypertension. JPKD had a poor predictive performance for low-body weight patients. The predictive performance of JPKD was decreased when the body weight was lower than 55.95 kg." @default.
• W3142912206 created "2021-04-13" @default.
• W3142912206 creator A5003667513 @default.
• W3142912206 creator A5004139292 @default.
• W3142912206 creator A5055493445 @default.
• W3142912206 creator A5072073206 @default.
• W3142912206 creator A5076259993 @default.
• W3142912206 creator A5090814462 @default.
• W3142912206 date "2021-03-01" @default.
• W3142912206 modified "2023-09-28" @default.
• W3142912206 title "[Predictive performance of Smart Dose, PharmVan and JPKD on Vancomycin plasma concentration]." @default.
• W3142912206 doi "https://doi.org/10.3760/cma.j.cn121430-20201016-00674" @default.
• W3142912206 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33834965" @default.
• W3142912206 hasPublicationYear "2021" @default.
• W3142912206 type Work @default.
• W3142912206 sameAs 3142912206 @default.
• W3142912206 citedByCount "0" @default.
• W3142912206 crossrefType "journal-article" @default.
• W3142912206 hasAuthorship W3142912206A5003667513 @default.
• W3142912206 hasAuthorship W3142912206A5004139292 @default.
• W3142912206 hasAuthorship W3142912206A5055493445 @default.
• W3142912206 hasAuthorship W3142912206A5072073206 @default.
• W3142912206 hasAuthorship W3142912206A5076259993 @default.
• W3142912206 hasAuthorship W3142912206A5090814462 @default.
• W3142912206 hasConcept C112705442 @default.
• W3142912206 hasConcept C126322002 @default.
• W3142912206 hasConcept C12868164 @default.
• W3142912206 hasConcept C144301174 @default.
• W3142912206 hasConcept C151956035 @default.
• W3142912206 hasConcept C2778980435 @default.
• W3142912206 hasConcept C2779489039 @default.
• W3142912206 hasConcept C2780272996 @default.
• W3142912206 hasConcept C2781413609 @default.
• W3142912206 hasConcept C2910800852 @default.
• W3142912206 hasConcept C3019719930 @default.
• W3142912206 hasConcept C38180746 @default.
• W3142912206 hasConcept C523546767 @default.
• W3142912206 hasConcept C54355233 @default.
• W3142912206 hasConcept C58471807 @default.
• W3142912206 hasConcept C71924100 @default.
• W3142912206 hasConcept C76318530 @default.
• W3142912206 hasConcept C86803240 @default.
• W3142912206 hasConceptScore W3142912206C112705442 @default.
• W3142912206 hasConceptScore W3142912206C126322002 @default.
• W3142912206 hasConceptScore W3142912206C12868164 @default.
• W3142912206 hasConceptScore W3142912206C144301174 @default.
• W3142912206 hasConceptScore W3142912206C151956035 @default.
• W3142912206 hasConceptScore W3142912206C2778980435 @default.
• W3142912206 hasConceptScore W3142912206C2779489039 @default.
• W3142912206 hasConceptScore W3142912206C2780272996 @default.
• W3142912206 hasConceptScore W3142912206C2781413609 @default.
• W3142912206 hasConceptScore W3142912206C2910800852 @default.
• W3142912206 hasConceptScore W3142912206C3019719930 @default.
• W3142912206 hasConceptScore W3142912206C38180746 @default.
• W3142912206 hasConceptScore W3142912206C523546767 @default.
• W3142912206 hasConceptScore W3142912206C54355233 @default.
• W3142912206 hasConceptScore W3142912206C58471807 @default.
• W3142912206 hasConceptScore W3142912206C71924100 @default.
• W3142912206 hasConceptScore W3142912206C76318530 @default.
• W3142912206 hasConceptScore W3142912206C86803240 @default.
• W3142912206 hasIssue "3" @default.
• W3142912206 hasLocation W31429122061 @default.
• W3142912206 hasOpenAccess W3142912206 @default.
• W3142912206 hasPrimaryLocation W31429122061 @default.
• W3142912206 hasRelatedWork W1982148262 @default.
• W3142912206 hasRelatedWork W2071733567 @default.
• W3142912206 hasRelatedWork W2085510857 @default.
• W3142912206 hasRelatedWork W2298114930 @default.
• W3142912206 hasRelatedWork W2315684163 @default.
• W3142912206 hasRelatedWork W2382198800 @default.
• W3142912206 hasRelatedWork W2474938719 @default.
• W3142912206 hasRelatedWork W2765727798 @default.
• W3142912206 hasRelatedWork W2896570919 @default.
• W3142912206 hasRelatedWork W2900965808 @default.
• W3142912206 hasRelatedWork W3006845749 @default.
• W3142912206 hasRelatedWork W3013922827 @default.
• W3142912206 hasRelatedWork W3024361906 @default.
• W3142912206 hasRelatedWork W3108397712 @default.
• W3142912206 hasRelatedWork W3118272734 @default.
• W3142912206 hasRelatedWork W3124559644 @default.
• W3142912206 hasRelatedWork W3161565 @default.
• W3142912206 hasRelatedWork W3173008490 @default.
• W3142912206 hasRelatedWork W3201730967 @default.
• W3142912206 hasRelatedWork W3203544942 @default.
• W3142912206 hasVolume "33" @default.
• W3142912206 isParatext "false" @default.
• W3142912206 isRetracted "false" @default.
• W3142912206 magId "3142912206" @default.
• W3142912206 workType "article" @default.